El Sherbini has been CEO of IDH since 2012. The company was listed on the London Stock Exchange in 2015. IDH had a network of 481 branch labs serving over seven million patients across Egypt, Jordan, Sudan, and Nigeria as of December 2020. It recorded assets worth $354.6 million and revenues of $239.3 million in the first nine months of 2021. El Sherbini has more than 30 years of experience in the healthcare sector. Before taking her current position, she served as the CEO of Al Mokhtabar for eight years. She also sits on the board of the American Society of Clinical Pathology (Egypt) and consults on the international certification process.